This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Abstract Details
|
Activity Number:
|
643
|
|
Type:
|
Invited
|
|
Date/Time:
|
Thursday, August 5, 2010 : 10:30 AM to 12:20 PM
|
|
Sponsor:
|
Statistical Society of Australia
|
| Abstract - #306061 |
|
Title:
|
Statistical Considerations in Cost-Effectiveness Assessments of New Medicines in Australia
|
|
Author(s):
|
Ian Marschner*+
|
|
Companies:
|
Macquarie University
|
|
Address:
|
Department of Statistics, Sydney, International, 2109, Australia
|
|
Keywords:
|
Cost-effectiveness ;
Surrogate outcomes ;
Pharmaceutical Industry ;
Indirect Comparisons
|
|
Abstract:
|
Most medicines in common usage in Australia are subsidized by the government. This means that new medicines typically undergo a detailed cost-effectiveness assessment, based on a submission from the drug's sponsor, to determine whether they should be added to the subsidized list. This presentation will discuss some of the statistical complexities of this process. These complexities often stem from the use of data that were collected for regulatory approval purposes rather than for establishing cost-effectiveness against current best practice. Statistical analysis guidelines have therefore been developed describing how to deal with such issues as surrogate outcomes and non-randomized treatment comparisons in cost-effectiveness submissions. The underlying statistical principles of these guidelines will be discussed and illustrated in the presentation.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2010 program
|
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.